Advertisement for orthosearch.org.uk
Results 1 - 20 of 20
Results per page:
Bone & Joint Research
Vol. 12, Issue 5 | Pages 311 - 312
5 May 2023
Xu C Liu Y

Cite this article: Bone Joint Res 2023;12(5):311–312.


Bone & Joint Research
Vol. 12, Issue 1 | Pages 5 - 8
1 Jan 2023
Im G

Cite this article: Bone Joint Res 2023;12(1):5–8.


Bone & Joint 360
Vol. 11, Issue 6 | Pages 3 - 4
1 Dec 2022
Ollivere B


The Bone & Joint Journal
Vol. 105-B, Issue 8 | Pages 837 - 838
1 Aug 2023
Kelly M McNally SA Dhesi JK


Bone & Joint Open
Vol. 5, Issue 9 | Pages 806 - 808
27 Sep 2024
Altorfer FCS Lebl DR


The Bone & Joint Journal
Vol. 105-B, Issue 6 | Pages 590 - 592
1 Jun 2023
Manktelow ARJ Mitchell P Haddad FS

Cite this article: Bone Joint J 2023;105-B(6):590–592.


The Bone & Joint Journal
Vol. 105-B, Issue 6 | Pages 587 - 589
1 Jun 2023
Kunze KN Jang SJ Fullerton MA Vigdorchik JM Haddad FS

The OpenAI chatbot ChatGPT is an artificial intelligence (AI) application that uses state-of-the-art language processing AI. It can perform a vast number of tasks, from writing poetry and explaining complex quantum mechanics, to translating language and writing research articles with a human-like understanding and legitimacy. Since its initial release to the public in November 2022, ChatGPT has garnered considerable attention due to its ability to mimic the patterns of human language, and it has attracted billion-dollar investments from Microsoft and PricewaterhouseCoopers. The scope of ChatGPT and other large language models appears infinite, but there are several important limitations. This editorial provides an introduction to the basic functionality of ChatGPT and other large language models, their current applications and limitations, and the associated implications for clinical practice and research.

Cite this article: Bone Joint J 2023;105-B(6):587–589.


Bone & Joint 360
Vol. 12, Issue 2 | Pages 3 - 4
1 Apr 2023
Rocos B Ruffles K


The Bone & Joint Journal
Vol. 106-B, Issue 6 | Pages 516 - 521
1 Jun 2024
Al-Hourani K Haddad FS


Bone & Joint 360
Vol. 11, Issue 4 | Pages 3 - 3
1 Aug 2022
Ollivere B


The Bone & Joint Journal
Vol. 104-B, Issue 2 | Pages 189 - 192
1 Feb 2022
Scott CEH Clement ND Davis ET Haddad FS


Bone & Joint 360
Vol. 10, Issue 4 | Pages 3 - 4
1 Aug 2021
Ollivere B



Bone & Joint Research
Vol. 10, Issue 2 | Pages 134 - 136
1 Feb 2021
Im G

The high prevalence of osteoarthritis (OA), as well as the current lack of disease-modifying drugs for OA, has provided a rationale for regenerative medicine as a possible treatment modality for OA treatment. In this editorial, the current status of regenerative medicine in OA including stem cells, exosomes, and genes is summarized along with the author’s perspectives. Despite a tremendous interest, so far there is very little evidence proving the efficacy of this modality for clinical application. As symptomatic relief is not sufficient to justify the high cost associated with regenerative medicine, definitive structural improvement that would last for years or decades and obviate or delay the need for joint arthroplasty is essential for regenerative medicine to retain a place among OA treatment methods.

Cite this article: Bone Joint Res 2021;10(2):134–136.


The Bone & Joint Journal
Vol. 102-B, Issue 12 | Pages 1597 - 1598
1 Dec 2020
Haddad FS


The Bone & Joint Journal
Vol. 102-B, Issue 10 | Pages 1277 - 1278
1 Oct 2020
Hughes R Hallstrom B Schemanske C Howard PW Wilton T


The Bone & Joint Journal
Vol. 101-B, Issue 5 | Pages 497 - 499
1 May 2019
Haddad FS


The Bone & Joint Journal
Vol. 100-B, Issue 4 | Pages 413 - 414
1 Apr 2018
Haddad FS


Bone & Joint 360
Vol. 2, Issue 4 | Pages 1 - 1
1 Aug 2013
Ollivere BJ


Bone & Joint 360
Vol. 2, Issue 3 | Pages 1 - 1
1 Jun 2013
Ollivere BJ